726 related articles for article (PubMed ID: 15894664)
101. Cervical cancer screening overuse and underuse: patient and physician factors.
Almeida CM; Rodriguez MA; Skootsky S; Pregler J; Steers N; Wenger NS
Am J Manag Care; 2013 Jun; 19(6):482-9. PubMed ID: 23844709
[TBL] [Abstract][Full Text] [Related]
102. Reported pap test use by Hispanic women in Connecticut and Long Island.
Polednak AP
Conn Med; 1996 Jan; 60(1):3-8. PubMed ID: 8821925
[TBL] [Abstract][Full Text] [Related]
103. Use of laboratory reports to assess cervical cancer screening in a community.
Orr ST; Celentano DD; Hill G; Erozan YS; Shediac M; Correa-Villasenor A; Matanoski G
Am J Prev Med; 1994; 10(4):235-7. PubMed ID: 7803067
[TBL] [Abstract][Full Text] [Related]
104. Beyond the Pap: assessing patients' priorities for the annual examination.
Becker HI; Longacre MR; Harper DM
J Womens Health (Larchmt); 2004 Sep; 13(7):791-8. PubMed ID: 15385073
[TBL] [Abstract][Full Text] [Related]
105. Cervical cancer screening among South Asian women in Canada: the role of education and acculturation.
Gupta A; Kumar A; Stewart DE
Health Care Women Int; 2002 Feb; 23(2):123-34. PubMed ID: 11868960
[TBL] [Abstract][Full Text] [Related]
106. Processes of care in cervical and breast cancer screening and follow-up--the importance of communication.
Zapka JG; Puleo E; Taplin SH; Goins KV; Ulcickas Yood M; Mouchawar J; Somkin C; Manos MM
Prev Med; 2004 Jul; 39(1):81-90. PubMed ID: 15207989
[TBL] [Abstract][Full Text] [Related]
107. Opportunities for enhanced cervical and breast screening referral in Charleston County.
Austin RM; Baron PL; Gates CE
J S C Med Assoc; 1993 Jul; 89(7):323-8. PubMed ID: 8412024
[TBL] [Abstract][Full Text] [Related]
108. The utilization of Pap test services of women: a nationwide study in Taiwan.
Lee FH; Wang HH
Cancer Nurs; 2011; 34(6):464-9. PubMed ID: 21372700
[TBL] [Abstract][Full Text] [Related]
109. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
Nash D; Chan C; Horowitz D; Vlahov D
J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
[TBL] [Abstract][Full Text] [Related]
110. Differences in rates of cancer screening by usual source of medical care. Data from the 1987 National Health Interview Survey.
Bernstein AB; Thompson GB; Harlan LC
Med Care; 1991 Mar; 29(3):196-209. PubMed ID: 1997750
[TBL] [Abstract][Full Text] [Related]
111. Prevalence and correlates of breast and cervical cancer screening among older women.
Ruchlin HS
Obstet Gynecol; 1997 Jul; 90(1):16-21. PubMed ID: 9207805
[TBL] [Abstract][Full Text] [Related]
112. Use of cervical and breast cancer screening among women with and without functional limitations--United States, 1994-1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(40):853-6. PubMed ID: 9790660
[TBL] [Abstract][Full Text] [Related]
113. Breast and cervical cancer screening disparities associated with disability severity.
Horner-Johnson W; Dobbertin K; Andresen EM; Iezzoni LI
Womens Health Issues; 2014; 24(1):e147-53. PubMed ID: 24439941
[TBL] [Abstract][Full Text] [Related]
114. Cervical cancer screening among women by hysterectomy status and among women aged ≥65 years - United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1043-7. PubMed ID: 23282862
[TBL] [Abstract][Full Text] [Related]
115. Predictors of Pap test use among women living on the Hopi reservation.
Coe K; Martin L; Nuvayestewa L; Attakai A; Papenfuss M; De Zapien JG; Seymour SS; Hunter J; Giuliano A
Health Care Women Int; 2007 Oct; 28(9):764-81. PubMed ID: 17907006
[TBL] [Abstract][Full Text] [Related]
116. Recency of Pap testing and future testing plans among women aged 18-64: analysis of the 2007 Health Information National Trends Survey.
Ashok M; Berkowitz Z; Hawkins NA; Tangka F; Saraiya M
J Womens Health (Larchmt); 2012 Jul; 21(7):705-12. PubMed ID: 22480224
[TBL] [Abstract][Full Text] [Related]
117. Validity of women's self-reports of cancer screening test utilization in a managed care population.
Caplan LS; McQueen DV; Qualters JR; Leff M; Garrett C; Calonge N
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1182-7. PubMed ID: 14652278
[TBL] [Abstract][Full Text] [Related]
118. Papanicolaou testing among Native American and Hispanic populations.
Moreland S; Engelman K; Greiner KA; Mayo MS
Ethn Dis; 2006; 16(1):223-7. PubMed ID: 16599374
[TBL] [Abstract][Full Text] [Related]
119. [Access to health care for an induced abortion: qualitative and quantitative approaches].
Bajos N; Moreau C; Ferrand M; Bouyer J
Rev Epidemiol Sante Publique; 2003 Dec; 51(6):631-47. PubMed ID: 14967996
[TBL] [Abstract][Full Text] [Related]
120. Cervical cancer screening in Malaysia: Are targeted interventions necessary?
Dunn RA; Tan AK
Soc Sci Med; 2010 Sep; 71(6):1089-93. PubMed ID: 20685019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
